𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

✍ Scribed by Pyrhönen, S; Kuitunen, T; Nyandoto, P; Kouri, M


Book ID
109837087
Publisher
Nature Publishing Group
Year
1995
Tongue
English
Weight
1018 KB
Volume
71
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Randomised trial of irinotecan plus supp
✍ David Cunningham; Seppo Pyrhönen; Roger D James; Cornelis JA Punt; Tamas F Hicki 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 169 KB

Background In phase II studies, irinotecan is active in metastatic colorectal cancer, but the overall benefit has not been assessed in a randomised clinical trial. Methods Patients with proven metastatic colorectal cancer, which had progressed within 6 months of treatment with fluorouracil, were ra